Dry Powder Inhalers (DPI)

Dry powder inhalers (DPIs) are regularly used to treat respiratory diseases. Adding extrinsic fine excipient particles to the blend of...

MEGGLE is a pioneer in co-processing technologies that allow simple, robust formulation development and manufacture. Through co-processing, MEGGLE developed highly...

MEGGLE is a pioneer in co-processing technologies that allow simple, robust formulation development and manufacture. Through co-processing, MEGGLE developed highly...

Purpose The objective of this study was to incorporate a passive cyclic loading strategy into the infant air-jet dry powder...

Dry powder inhalers (DPIs) can be used with a wide range of drugs such as small molecules and biologics and...

While all the siRNA drugs on the market target the liver, the lungs offer a variety of currently undruggable targets which could...

FlowLac by MEGGLE is directly compressible lactose having a spherical agglomerate shape, consisting of small alpha-lactose monohydrate crystals bound by...

RetaLac® by MEGGLE is a co-processed excipient comprising of equal parts of milled alpha-lactose monohydrate and hypromellose (USP substitution type...

Pulmonary drug delivery has gained great attention in local or systemic diseases therapy, however it is still difficult to scale-up DPI production due to the...

Excipients for direct tabletting and  granulation   Product Description Lactose Overview Lactose is a disaccharide of glucose and galactose obtained...